![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, January 28, 2020 5:27:41 PM
I would like to know the status of the patent that is pending. I would like to know more about the Elixer CBD project. I would like to know more about our line of credit. What is the interest rate for example. We don’t hear many details about Prolayed. What sorts of sales figures can we expect for Vitastem , Prolayed and other products online and at Amazon?
There are many questions that an investor should have with VDRM because news flow from the company has been notably sparse for 18 months. We did get a blip of info 8 days ago from Dr, Otiko that he is behind the scenes and working hard for us, the shareholders. (Stock price more than doubled on that). We also see a 2020 add for Elixer mentioning Viaderma transdermal technology.
We need to know that the company is trying to stay current with the OTC reporting requirements. The Stop Sign is bad publicity. With a new line of credit this should be a priority to get done.
I think IR is allowed to say what they are doing and planning to get done if widely disseminated. In terms of complying with fair disclosure rules and any possible lawsuit it might be smartest and easiest to say nothing at all to investors.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM